Multiple factors might impinge in TAp73 overexpression in cancer cells, including E2F1‐mediated regulation of TAp73 transcription [57], especially in the context of p53‐inactivation [105], or TAp73 stabilization under hypoxic conditions via HIF1‐α [106], among other possible mechanisms. Here, E2F1 is linked to cancer.